124 related articles for article (PubMed ID: 17110097)
1. The prognostic value of proliferation in lymph-node-negative breast cancer patients is age dependent.
Baak JP; van Diest PJ; Voorhorst FJ; van der Wall E; Beex LV; Vermorken JB; Janssen EA; Gudlaugsson E;
Eur J Cancer; 2007 Feb; 43(3):527-35. PubMed ID: 17110097
[TBL] [Abstract][Full Text] [Related]
2. Multivariate prognostic evaluation of the mitotic activity index and fibrotic focus in node-negative invasive breast cancers.
Baak JP; Colpaert CG; van Diest PJ; Janssen E; van Diermen B; Albernaz E; Vermeulen PB; Van Marck EA
Eur J Cancer; 2005 Sep; 41(14):2093-101. PubMed ID: 16153819
[TBL] [Abstract][Full Text] [Related]
3. Prospective multicenter validation of the independent prognostic value of the mitotic activity index in lymph node-negative breast cancer patients younger than 55 years.
Baak JP; van Diest PJ; Voorhorst FJ; van der Wall E; Beex LV; Vermorken JB; Janssen EA
J Clin Oncol; 2005 Sep; 23(25):5993-6001. PubMed ID: 16135467
[TBL] [Abstract][Full Text] [Related]
4. [Proliferation index and its prognostic value in invasive ductal breast carcinoma].
Falco M
Ann Acad Med Stetin; 2009; 55(1):22-30. PubMed ID: 20349588
[TBL] [Abstract][Full Text] [Related]
5. Mitotic activity and bone marrow micrometastases have independent prognostic value in node positive breast cancer patients.
Gilje B; Nordgård O; Tjensvoll K; Janssen EA; Søiland H; Smaaland R; Baak JP
Breast Cancer Res Treat; 2011 Jul; 128(1):137-46. PubMed ID: 21476002
[TBL] [Abstract][Full Text] [Related]
6. In lymph node-negative invasive breast carcinomas, specific chromosomal aberrations are strongly associated with high mitotic activity and predict outcome more accurately than grade, tumour diameter, and oestrogen receptor.
Janssen EA; Baak JP; Guervós MA; van Diest PJ; Jiwa M; Hermsen MA
J Pathol; 2003 Dec; 201(4):555-61. PubMed ID: 14648658
[TBL] [Abstract][Full Text] [Related]
7. In primary breast cancer the mitotic activity yields similar prognostic information as the histological grade: a study with long-term follow-up.
Bult P; Manders P; Straatman HM; Tjan-Heijnen VC; Beex LV; Hendriks J; Leer JW; Verbeek AL; Holland R
Breast Cancer Res Treat; 2010 Jul; 122(1):77-86. PubMed ID: 19760038
[TBL] [Abstract][Full Text] [Related]
8. Proliferation is the strongest prognosticator in node-negative breast cancer: significance, error sources, alternatives and comparison with molecular prognostic markers.
Baak JP; Gudlaugsson E; Skaland I; Guo LH; Klos J; Lende TH; Søiland H; Janssen EA; Zur Hausen A
Breast Cancer Res Treat; 2009 May; 115(2):241-54. PubMed ID: 18665447
[TBL] [Abstract][Full Text] [Related]
9. 'Blind' multicenter evaluation of the prognostic value of DNA image cytometric and morphometric features in invasive breast cancer.
Theissig F; Baak JP; Schuurmans L; Haroske G; Meyer W; Kunze KD
Anal Cell Pathol; 1996 Mar; 10(2):85-99. PubMed ID: 8721952
[TBL] [Abstract][Full Text] [Related]
10. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
Di Saverio S; Catena F; Santini D; Ansaloni L; Fogacci T; Mignani S; Leone A; Gazzotti F; Gagliardi S; De Cataldis A; Taffurelli M
Breast Cancer Res Treat; 2008 Jun; 109(3):405-16. PubMed ID: 17687650
[TBL] [Abstract][Full Text] [Related]
11. Validation of 70-gene prognosis signature in node-negative breast cancer.
Bueno-de-Mesquita JM; Linn SC; Keijzer R; Wesseling J; Nuyten DS; van Krimpen C; Meijers C; de Graaf PW; Bos MM; Hart AA; Rutgers EJ; Peterse JL; Halfwerk H; de Groot R; Pronk A; Floore AN; Glas AM; Van't Veer LJ; van de Vijver MJ
Breast Cancer Res Treat; 2009 Oct; 117(3):483-95. PubMed ID: 18819002
[TBL] [Abstract][Full Text] [Related]
12. Prognostic differences of World Health Organization-assessed mitotic activity index and mitotic impression by quick scanning in invasive ductal breast cancer patients younger than 55 years.
Skaland I; van Diest PJ; Janssen EA; Gudlaugsson E; Baak JP
Hum Pathol; 2008 Apr; 39(4):584-90. PubMed ID: 18291440
[TBL] [Abstract][Full Text] [Related]
13. Microvessel density compared with the Chalkley count in a prognostic study of angiogenesis in breast cancer patients.
Hansen S; Sørensen FB; Vach W; Grabau DA; Bak M; Rose C
Histopathology; 2004 May; 44(5):428-36. PubMed ID: 15139990
[TBL] [Abstract][Full Text] [Related]
14. A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma.
Di Saverio S; Gutierrez J; Avisar E
Breast Cancer Res Treat; 2008 Oct; 111(3):541-7. PubMed ID: 18026874
[TBL] [Abstract][Full Text] [Related]
15. Prospective multicenter comparison of proliferation and other prognostic factors in lymph node negative lobular invasive breast cancer.
Gudlaugsson E; Skaland I; Janssen EA; van Diest PJ; Voorhorst FJ; Kjellevold K; zur Hausen A; Baak JP
Breast Cancer Res Treat; 2010 May; 121(1):35-40. PubMed ID: 19568929
[TBL] [Abstract][Full Text] [Related]
16. [Clinical characteristics and prognostic factors of female breast cancer patients with 10 or more positive lymph nodes: a report of 128 patients].
Guan Y; Xu BH; Li Q; Zhang P; Zhao LM; Yuan P; Wang JY
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(2):77-81. PubMed ID: 18353207
[TBL] [Abstract][Full Text] [Related]
17. Validating the prognostic value of proliferation measured by Phosphohistone H3 (PPH3) in invasive lymph node-negative breast cancer patients less than 71 years of age.
Skaland I; Janssen EA; Gudlaugsson E; Klos J; Kjellevold KH; Søiland H; Baak JP
Breast Cancer Res Treat; 2009 Mar; 114(1):39-45. PubMed ID: 18373192
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of necrosis in Nigerian breast cancer.
Ikpatt O; Ndoma-Egba R; Collan Y
Adv Clin Path; 2002 Jan; 6(1):31-7. PubMed ID: 17582946
[TBL] [Abstract][Full Text] [Related]
19. Proliferation in African breast cancer: biology and prognostication in nigerian breast cancer material.
Ikpatt OF; Kuopio T; Collan Y
Mod Pathol; 2002 Aug; 15(8):783-9. PubMed ID: 12181262
[TBL] [Abstract][Full Text] [Related]
20. [Breast-conservation treatment for early invasive breast cancer: prognostic factors for survival after salvage treatment of local recurrence].
Fodor J
Magy Onkol; 2007; 51(2):127-31. PubMed ID: 17660868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
